|
|
|
40
|
0081AG
|
AMPHOTIN 50MG INJ (UBI/RXP) AMPHOTERICIN B
|
AMPHOTERICIN B
|
AMPHOTIN
|
50MG VIAL
|
BQ
|
19.71
|
19.71
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
081428
|
POLYENES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0301Q
|
CLINDATECH 150MG/ML INJ (UBI/RXP) CLINDAMYCIN
|
CLINDAMYCIN PHOSPHATE
|
CLINDATECH
|
2ML AMP
|
BQ
|
6.12
|
6.12
|
INJECTION
|
0
|
AMP
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
05217
|
DACTINOTEC 500MCG INJ (UBI/RXP) ACTINOMYCIN D
|
ACTINOMYCIN D
|
DACTINOTEC
|
500MCG
|
BQ
|
31.26
|
31.26
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0582D
|
ONCOTAR 1G INJ (UBI/RXP) CYTARABINE
|
CYTARABINE
|
ONCOTAR
|
1G VIAL
|
BQ
|
31.26
|
31.26
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0633X
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
METHOTREXATE
|
UNITREXATE
|
2ML VIAL
|
B
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0671D
|
UNIBLASTIN 10MG INJ (UBI/RXP) VINBLASTINE
|
VINBLASTINE
|
UNIBLASTIN
|
10MG VIAL
|
BQ
|
54.37
|
54.37
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0681Q
|
UNICRISTINE 1MG INJ (UBI/RXP) VINCRISTINE
|
VINCRISTINE
|
UNICRISTINE
|
1MG VIAL
|
BQ
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
2353D
|
PHRINTEC 10MG/ML IV/IM INJ (UBI/RXP) PHENYLEP
|
PHENYLEPHRINE
|
PHRINTEC
|
1ML VIAL
|
B
|
10.60
|
10.60
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
121204
|
ALPHA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
2931Y
|
VASMED 20U/ML INJ (UBI/RXP) VASOPRESSIN
|
VASOPRESSIN
|
VASMED
|
1ML AMP
|
BQ
|
10.47
|
10.47
|
INJECTION
|
0
|
AMP
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
6828
|
PITUITARY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
4222H
|
MUCOSYS 20% INJ (UBI/RXP) ACETYLCYSTEINE
|
ACETYLCYSTEINE
|
MUCOSYS
|
10ML
|
BQ
|
8.83
|
8.83
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
9212
|
ANTIDOTES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
4463M
|
DONEPEZIL 5MG TAB (JUB/AHI)
|
DONEPEZIL
|
DONEPEZIL
|
90'S
|
A
|
25.82
|
0.29
|
TABLET
|
30
|
TAB
|
JUB
|
JUBILANT LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
deleted from Contract
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4463M
|
DONEPEZIL 5MG TAB (JUB/AHI)
|
DONEPEZIL
|
DONEPEZIL
|
90'S
|
A
|
25.82
|
0.29
|
TABLET
|
30
|
TAB
|
JUB
|
JUBILANT LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
deleted from Contract
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
5422J
|
TOCIN 40MG/ML INJ (UBI/RXP) TOBRAMYCIN
|
TOBRAMYCIN
|
TOCIN
|
2ML VIAL
|
BQ
|
8.97
|
8.97
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
081202
|
AMINOGLYCOSIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A1917
|
BIOGLANDIN 500MCG/ML INJ (UBI/RXP) ALPROSTADI
|
ALPROSTADIL
|
BIOGLANDIN
|
1ML AMP
|
BQ
|
237.85
|
237.85
|
INJECTION
|
0
|
AMP
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
241292
|
VASODILATING AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
